Tolochenaz, Vaud, Switzerland — Nanolive SA, an industry leader in live cell imaging and analysis, announces the appointment of Line Stigen Raquet as new Chief Commercial Officer.

Nanolive, a leading provider of phenotypic screening solutions for in vitro live cell imaging and analysis, is pleased to announce the appointment of Line Stigen Raquet as the company’s new Chief Commercial Officer. With a proven track record as a C-Suite transformational leader and commercial strategist, Line will play a key role in scaling Nanolive’s business performance and driving corporate growth in the competitive life sciences sector.

Line Stigen Raquet is a highly respected leader in the industry, known for her ability to navigate diverse markets worldwide. She brings a wealth of experience in global leadership, project management, and enterprise-wide change strategy. Line’s expertise in establishing and leveraging strong relationships across different cultures has been instrumental in maximizing value creation for industry-leading life sciences organizations.

Throughout her career, Line has achieved remarkable success in transforming companies and driving commercial outcomes. She spearheaded the transformation of Creoptix, a start-up, into a commercially successful and viable company within a short span of 12 months, even amidst the challenges posed by the coronavirus pandemic.

As an out-of-the-box thinker and innovative leader, Line has consistently conceptualized and implemented blueprints that have propelled top-line revenues and bottom-line outcomes. Her ability to galvanize management teams worldwide and surpass commercial targets has been a driving force behind her success.

Commenting on her appointment, Line Stigen Raquet stated, “I am thrilled to join Nanolive, a company that is at the forefront of innovation in the life sciences sector. I look forward to working with the talented team at Nanolive and contributing to the company’s continued growth and success. Together, we will drive commercial excellence, develop strategic partnerships, and bring cutting-edge solutions to accelarate drug development”

Nanolive CEO, Dr. Yann Cotte, expressed his excitement about Line joining the company, stating, “We are delighted to welcome Line Stigen Raquet to Nanolive. Her remarkable leadership experience, commercial acumen, and transformative vision make her the perfect fit for this role. We are confident that Line’s expertise will drive Nanolive to new heights and strengthen our position as a global leader in the live cell imaging and analysis industry. Together, we are committed to empower our customers in their journey from cells to patients.”

About Nanolive SA

Nanolive develops and manufactures label-free, tomographic, high content live cell imaging platforms and integrated digital analytical solutions powered by machine learning, to qualitatively and quantitatively analyze cells label-free. Nanolive’s first-in-class solutions have repeatedly been recognized by The Scientist’s Top 10 innovations in 2022 (The LIVE T Cell Assay), 2019, and 2015 (the CX-A and Cell Explorer imaging platforms, respectively). Nanolive is headquartered in Tolochenaz, Switzerland with staff worldwide including in France, Germany, and across the US where it operates as Nanolive Inc.

Recently published peer-reviewed papers where Nanolive imaging has been used are listed on Nanolive’s website.

For Media Inquiries:

Nanolive SA

Route de Lully, 5B

1131 Tolochenaz

Switzerland

[email protected]